Trifluridine

Specifications

70-00-8CAS Number

200-722-8EC Number

1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-(trifluoromethyl)pyrimidine-2,4-dioneIUPAC Name

C10H11F3N2O5Chemical Formula

296.2 g/molMolecular Weight

Trifluridine; TRIFLUOROTHYMIDINE; 70-00-8; Viroptic; Trifluoromethyldeoxyuridine; F3DThd; Trifluridina; F3TDR; Trifluridinum; 5-(Trifluoromethyl)deoxyuridine; TFDU; 5-Trifluoromethyl-2-deoxyuridine; 2'-Deoxy-5-(trifluoromethyl)uridine; Trifluorothymine deoxyriboside; 5-Trifluoromethyl-2'-deoxyuridine; 2'-Deoxy-5-trifluoromethyluridine; 5-Trifluoro-2'-deoxythymidine; DTXSID4046602; CCRIS 2348; Thymidine, alpha,alpha,alpha-trifluoro-; RMW9V5RW38; NSC-75520; NSC-529182; 1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-(trifluoromethyl)pyrimidine-2,4-dione; DTXCID2026602; CHEBI:75179; NSC75520; 2,4(1H,3H)-Pyrimidinedione, 1-(2-deoxy-beta-D-ribofuranosyl)-5-(trifluoromethyl)-; 1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-(trifluoromethyl)-1,2,3,4-tetrahydropyrimidine-2,4-dione; Triherpine; triflorothymidine; 5 Trifluoromethyl 2' deoxyuridine; 1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl)-5-(trifluoromethyl)-1,2,3,4-tetrahydropyrimidine-2,4-dione; 1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl)-5-(trifluoromethyl)pyrimidine-2,4-dione; RefChem:57685; S01AD02; 200-722-8; 5-Trifluorothymidine; Virophta; MFCD00006534; 1-((2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-(trifluoromethyl)pyrimidine-2,4(1H,3H)-dione; Trifluridine (Viroptic); Uridine, 2'-deoxy-5-(trifluoromethyl)-; CHEMBL1129; MLS000028361; C10H11F3N2O5; alpha,alpha,alpha-Trifluorothymidine; F3T; Fluridine; SMR000058583; Trifluridinum [INN-Latin]; Trifluridina [INN-Spanish]; 1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-(trifluoromethyl)pyrimidine-2,4-dione; 5-(Trifluoromethyl)-2'-deoxyuridine; CF3dUrd; NSC 75520; Viroptic (TN); 5-Trifluoromethylthymidine; EINECS 200-722-8; UNII-RMW9V5RW38; NSC 529182; BRN 0568095; NSC529182; Trifluridine [USAN:USP:INN]; HSDB 8126; Trifluridine CRS; CAS-70-00-8; NCGC00166323-01; Trifluoro-D-thymidine; HS-0007; Trifluridine (Standard); Opera_ID_1810; TRIFLURIDINE [MI]; TRIFLURIDINE [INN]; TRIFLURIDINE [JAN]; ?,?,?-Trifluorothymidine; Trifluoromethyl Deoxyuridine; TRIFLURIDINE [USAN]; cid_6256; SCHEMBL3479; TRIFLURIDINE [VANDF]; TRIFLURIDINE [MART.]; MLS001148248; MLS006010219; TRIFLURIDINE [USP-RS]; TRIFLURIDINE [WHO-DD]; Trifluridine (JAN/USP/INN); GTPL8697; orb1224196; orb1308655; Trifluorothymidine; Trifluridine; cid_6708818; HY-A0061R; GLXC-07756; HMS2233N19; HMS3715C14; TRIFLURIDINE [ORANGE BOOK]; TRIFLURIDINE [EP MONOGRAPH]; 5-trifluoromethyl-2''-deoxyuridine; HY-A0061; Tox21_112411; TRIFLURIDINE [USP MONOGRAPH]; BDBM50132298; EBC-11058; Trifluorothymidine, >=99% (HPLC); AKOS015919482; Tox21_112411_1; CCG-221056; CS-1602; DB00432; NT04884; TAS-102 COMPONENT TRIFLURIDINE; NCGC00166323-02; NCGC00166323-16; NCGC00166323-17; S-95005 COMPONENT TRIFLURIDINE; BP-58659; SRI-10817-12; SRI-10817_14; SY076940; S1778; SW199522-2; D00391; Thymidine, .alpha.,.alpha.,.alpha.-trifluoro-; EN300-24409722; F076337; SR-01000721911; Q2359590; SR-01000721911-2; BRD-K03243820-001-12-1; BRD-K03243820-001-22-0; BRD-K03243820-001-23-8; BRD-K03243820-001-25-3; Trifluridine, British Pharmacopoeia (BP) Reference Standard; Trifluridine;FTD;5-Trifluorothymidine;NSC 529182;NSC 75520; Trifluridine, United States Pharmacopeia (USP) Reference Standard; 1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)-5-(trifluoromethyl)pyrimidine-2,4(1H,3H)-dione; 1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-(trifluoromethyl)pyrimidine-2,4(1H,3H)-dione.; 1-((2R,5R)-4-Hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-trifluoromethyl-1H-pyrimidine-2,4-dione; 1-[(2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)-2-tetrahydrofuryl]-5-(trifluoromethyl)pyrimidine-2,4(1H,3H)-dione; Trifluridine; Trifluorothymine Deoxyriboside; 1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-(trifluoromethyl)pyrimidine-2,4(1H,3H)-dioneSynonyms